Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Niso Biomed has developed EndoFaster, a real-time gastric juice analysis system that integrates with endoscopes to provide immediate chemical data during gastroscopy. This enables rapid diagnosis of H. pylori infection and assessment of hypochlorhydria—key risk factors for gastric cancer—improving biopsy strategy and potentially reducing unnecessary histology. The technology is used clinically across Europe, with additional research into expanding its applications to other cancers such as childhood neuroblastoma via urine marker detection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Niso Biomed.